Raymond James & Associates’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.75M | Sell |
193,566
-62,196
| -24% | -$884K | ﹤0.01% | 2020 |
|
|
2024
Q2 | $3.31M | Buy |
255,762
+12,862
| +5% | +$166K | ﹤0.01% | 1860 |
|
|
2024
Q1 | $3.37M | Buy |
242,900
+20,531
| +9% | +$285K | ﹤0.01% | 1834 |
|
|
2023
Q4 | $3.17M | Buy |
222,369
+57,134
| +35% | +$815K | ﹤0.01% | 1811 |
|
|
2023
Q3 | $2.56M | Sell |
165,235
-6,750
| -4% | -$104K | ﹤0.01% | 1858 |
|
|
2023
Q2 | $2.7M | Buy |
171,985
+29,420
| +21% | +$462K | ﹤0.01% | 1870 |
|
|
2023
Q1 | $2.35M | Buy |
142,565
+14,761
| +12% | +$243K | ﹤0.01% | 1930 |
|
|
2022
Q4 | $1.99M | Buy |
127,804
+24,949
| +24% | +$389K | ﹤0.01% | 1988 |
|
|
2022
Q3 | $1.33M | Sell |
102,855
-9,933
| -9% | -$129K | ﹤0.01% | 2219 |
|
|
2022
Q2 | $1.58M | Sell |
112,788
-19,438
| -15% | -$273K | ﹤0.01% | 2147 |
|
|
2022
Q1 | $1.89M | Buy |
132,226
+29,087
| +28% | +$416K | ﹤0.01% | 2164 |
|
|
2021
Q4 | $1.41M | Sell |
103,139
-122,402
| -54% | -$1.67M | ﹤0.01% | 2407 |
|
|
2021
Q3 | $3.69M | Sell |
225,541
-17,631
| -7% | -$289K | ﹤0.01% | 1698 |
|
|
2021
Q2 | $4.09M | Buy |
243,172
+16,540
| +7% | +$278K | ﹤0.01% | 1621 |
|
|
2021
Q1 | $4.14M | Sell |
226,632
-783,817
| -78% | -$14.3M | ﹤0.01% | 1553 |
|
|
2020
Q4 | $18.4M | Sell |
1,010,449
-80,564
| -7% | -$1.47M | 0.02% | 659 |
|
|
2020
Q3 | $19.5M | Sell |
1,091,013
-73,894
| -6% | -$1.32M | 0.02% | 550 |
|
|
2020
Q2 | $20.9M | Sell |
1,164,907
-47,324
| -4% | -$849K | 0.03% | 501 |
|
|
2020
Q1 | $18.4M | Buy |
1,212,231
+174,691
| +17% | +$2.65M | 0.03% | 483 |
|
|
2019
Q4 | $20.5M | Buy |
1,037,540
+85,410
| +9% | +$1.69M | 0.03% | 571 |
|
|
2019
Q3 | $16.4M | Buy |
952,130
+263,461
| +38% | +$4.53M | 0.02% | 638 |
|
|
2019
Q2 | $12.2M | Buy |
688,669
+186,425
| +37% | +$3.3M | 0.02% | 757 |
|
|
2019
Q1 | $10.2M | Buy |
502,244
+459,051
| +1,063% | +$9.35M | 0.02% | 816 |
|
|
2018
Q4 | $727K | Buy |
+43,193
| New | +$727K | ﹤0.01% | 2290 |
|